Chronic Kidney Disease Stage 3 Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Chronic Kidney Disease Stage 3 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes

Type 2 DiabetesChronic Kidney Disease Stage 3
Heba Al-Alwan76 enrolled2 locationsNCT06925217
Recruiting
Phase 3

Patiromer and Diet/hrQoL in Chronic Dialysis

Dietary InterventionChronic Kidney Disease Stage 3 and 4Hyperkalaemia
Mario Negri Institute for Pharmacological Research40 enrolled1 locationNCT06858280
Recruiting

Urinary Tubular Biomarkers for Chronic Kidney Disease

Chronic Kidney Disease Stage 3
Erasmus Medical Center556 enrolled1 locationNCT06732349
Recruiting
Phase 2

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Metabolic Dysfunction-Associated SteatohepatitisChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 2
Enyo Pharma60 enrolled1 locationNCT06939816
Recruiting
Not Applicable

Exercise Activity to Improve Mobility in Patients With CKD and PAD

Chronic Kidney Disease Stage 3 and 4Peripheral Artery Disease (PAD)
University Hospital of Ferrara124 enrolled3 locationsNCT06621264
Recruiting
Phase 2

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Chronic Kidney Disease Stage 3Chronic Renal FailureMechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis+1 more
Klinikum Nürnberg100 enrolled2 locationsNCT05884866
Recruiting

Prediction of Peripheral Neuropathy With Functional Testing

DiabetesChronic Kidney Disease Stage 3 and 4
Université catholique de l'Ouest70 enrolled1 locationNCT06933108
Recruiting
Phase 1Phase 2

A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)

Chronic Kidney Disease Stage 3
AION Healthspan, Inc.36 enrolled1 locationNCT06721143
Recruiting
Not Applicable

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease stage4Chronic Kidney Disease Stage 5Chronic Kidney Disease Stage 3B+1 more
Dr. Schär AG / SPA244 enrolled21 locationsNCT05489120